You've been told it's normal. But what if it's not.

You're standing in the shower holding a clump of hair larger than anything you've seen before. You mention it to your OB. "Completely normal," they say. "Hormones. It'll stop." You Google it and same answer everywhere. Telogen effluvium. Temporary. Don't worry.
Months pass. It doesn't stop. Or it slows down, but your hair never quite comes back to what it was. The density at the top looks different. The part is wider. Something is still wrong and you can't get a straight answer from anyone.
This article explains why and what a real evaluation actually looks at.

The problem with "it's just postpartum shedding"

Postpartum telogen effluvium is real. During pregnancy, elevated estrogen keeps a higher percentage of your hair in the growth phase. After delivery, estrogen drops sharply and all that retained hair enters the shedding phase at once. The result: dramatic diffuse shedding starting around 2–4 months postpartum. That part is textbook. What isn't taught is what else might be happening underneath it.

In a clinical study of 200 women presenting with postpartum hair loss, only 9.5% had pure telogen effluvium. Over 56% had concurrent androgenetic alopecia being unmasked by the postpartum hormonal drop. 28% had three concurrent diagnoses. Telogen effluvium resolves on its own. Androgenetic alopecia does not it progresses. If your postpartum shedding is triggering underlying female pattern hair loss you didn't know you had, treating it as temporary means losing a critical early intervention window.

Why your dermatologist probably missed this

Standard dermatology appointments run 10–15 minutes. The presentation is a new mother with diffuse shedding. The textbook answer is telogen effluvium. Minoxidil is prescribed, or a "wait and see" approach is recommended, and the consultation ends. What gets skipped: pattern analysis of where density loss is occurring, whether miniaturization is present at the scalp level, whether the frontal hairline is preserved or receding, the full hormonal history including contraceptive use before pregnancy, and whether traction patterns from hairstyling habits are contributing. None of this requires bloodwork. It requires time, attention, and proper photographic documentation.

The signs that something more is going on

With pure telogen effluvium: shedding is diffuse across the entire scalp, regrowth appears uniformly, part width returns to baseline, and the frontal hairline stays stable. With TE unmasking AGA: shedding is more pronounced at the crown and frontal-parietal region, regrowth hairs come back thinner and shorter than the original hair, the part gradually widens over months, and density doesn't fully restore. The critical window is the first 6 months postpartum. If the pattern of regrowth looks or feels different from what came out — if the new hair is finer, weaker, or the density doesn't return and that is the signal.

What proper evaluation actually looks at

A photo-based scalp assessment evaluates dermoscopic pattern whether regrowing hairs are uniform in diameter or showing miniaturization, which is the hallmark of androgenetic progression and does not appear in bloodwork. It maps distribution to distinguish telogen effluvium from female pattern hair loss. It examines hairline architecture for signs of traction alopecia, a frequently missed concurrent diagnosis caused directly by hairstyling habits and fully reversible if caught early. It also takes into account the full hormonal and medication context: contraceptive history, thyroid status, PCOS, and post-pill timing all of which affect which diagnosis is most likely and which treatments are appropriate versus contraindicated.

What treatment looks like and when the time is right

If the assessment confirms pure telogen effluvium, the approach is supportive: monitoring, nutritional optimization, scalp health, and a clear timeline for expected resolution. No aggressive intervention needed. If AGA is confirmed alongside TE, early-stage female AGA is significantly more responsive to treatment than advanced stages. The goal is stopping miniaturization progression before years of loss accumulate. Minoxidil, targeted supplements, and microneedling protocols form the foundation depending on severity and breastfeeding status. If traction alopecia is part of the picture, the intervention is a change in hairstyling habits : no drug, no supplement, just a behavioral correction that can show visible results within months. The treatment depends entirely on the diagnosis. Getting the diagnosis right is not a step you can skip.

No payment. No subscription. No obligation. If you've been shedding for more than 8 weeks without a proper scalp assessment, you are making treatment decisions without a real diagnosis. Upload your photos

Dr. Ghorbani reviews every case personally within 48 hours.